Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
boston blog main
boston top stories
2
×
life sciences
national blog main
national top stories
ally bridge group
big data analytics
biotech
blackrock
casdin capital
clinical trials
crispr
david walt
deals
diabetic nephropathy
diagnostics
eventide asset management
feng zhang
focal segmental glomerulosclerosis
gene editing
goldfinch bio
illumina
irving investors
jay ghosh
jennifer doudna
jim collins
mammoth biosciences
san francisco blog main
san francisco top stories
schroeder adveq
software
startups
the broad institute of mit and harvard
third rock ventures
vc
wellington management company
yonjin capital
What
bio
2
×
diseases
2
×
medicines
analysis
biotech
bring
company
create
crispr
develop
diagnostic
drug
editing
employing
fix
gene
genetic
goldfinch
heats
high
human
ipo
kidney
later
launches
lead
million
new
race
raised
raises
sherlock
stakes
studies
technology
trials
underway
use
years
Language
unset
Current search:
diseases
×
" boston top stories "
×
bio
×
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M